Inhibiting the nuclear exporter XPO1 and the antiapoptotic factor BCL2 is synergistic in XPO1 and SF3B1 mutant hematologic malignancies.

被引：0
|
作者：
Totiger, Tulasigeri M. [1 ]
Chaudhry, Sana [1 ]
Afaghani, Jumana [1 ]
Taylor, Justin [1 ]
机构：
[1] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1341
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Inhibiting the Nuclear Exporter XPO1 and the Antiapoptotic Factor BCL2 Is Synergistic in XPO1 Mutant and Wildtype Lymphoma
    Owusu-Ansah, Frank
    Afaghani, Jumana
    Lee, Stanley
    Taylor, Justin
    BLOOD, 2020, 136
  • [2] Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer
    Sexton, Rachel
    Mahdi, Zaid
    Chaudhury, Rahman
    Beydoun, Rafic
    Aboukameel, Amro
    Khan, Husain Y.
    Baloglu, Erkan
    Senapedis, William
    Landesman, Yosef
    Tesfaye, Anteneh
    Kim, Steve
    Philip, Philip A.
    Azmi, Asfar S.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (19)
  • [3] Selective activity of XPO1 inhibitors in TET2-mutant myeloid malignancies
    Prutsch, Nicole
    Jing, Chang-Bin
    Etchin, Julia
    Berezovskaya, Alla
    Tiv, Hong
    Poitras, Michael J.
    Gokhale, Prafulla
    Landesman, Yosef
    Look, A. Thomas
    CANCER RESEARCH, 2019, 79 (13)
  • [4] XPO1 inhibitors in the treatment of hematologic malignancies: from preclinical findings to clinical studies
    Rahme, Ramy
    Braun, Thorsten
    HEMATOLOGIE, 2023, 29 (03): : 157 - 170
  • [5] Nuclear exporter protein XPO1 a novel prognostic and therapeutic target in gastric cancer
    Muqbil, Irfana
    Mahdi, Zaid
    Choudhary, Rahman
    Baloglu, Erkan
    Senapedis, William
    Landesman, Yosef
    Shacham, Sharon
    Kauffman, Michael
    Kim, Steve
    Beydoun, Rafic
    Berri, Richard N.
    Shields, Anthony
    Mohammad, Ramzi M.
    Azmi, Asfar S.
    CANCER RESEARCH, 2018, 78 (13)
  • [6] Nuclear exporter protein exportin 1 (XPO1) as a novel therapeutic target in pancreatic neuroendocrine tumors
    Azmi, A. S.
    Uddin, M. H.
    Bannoura, S. F.
    Khan, H. M.
    Diab, M.
    Kim, S.
    Beal, E.
    Tobon, M.
    Chen, H.
    Beydoun, R.
    Dyson, G.
    Mohammad, R. M.
    Philip, P. A.
    Al-Hallak, M. N.
    El-Rayes, B. F.
    Pasche, B.
    ANNALS OF ONCOLOGY, 2024, 35 : S97 - S97
  • [7] Inhibition of BCL2 and XPO1 demonstrates synergistic effects in triple-negative breast cancer cell lines
    Jackson, Marilyn Marie
    Smoots, Stephen G.
    Dominguez, Adrian T.
    Dus, Evan
    Bagby, Stacey
    Binns, Cameron
    Pitts, Todd M.
    Diamond, Jennifer R.
    CANCER RESEARCH, 2024, 84 (06)
  • [8] Nuclear Exporter Protein CRM1/XPO1 a Novel Prognostic and Therapeutic Target in Gastric Cancer
    Mandi, Zaid
    Chaudhary, Rahman
    Muqbil, Irfana
    Aboukameel, Amro
    Mohammad, Ramzi
    Philip, Philip
    Senapedis, William
    Beydoun, Rafic
    Azmi, Asfar
    LABORATORY INVESTIGATION, 2017, 97 : 185A - 185A
  • [9] Next Generation XPO1 Inhibitor Shows Improved Efficacy and In Vivo Tolerability in Hematologic Malignancies
    Hing, Zachary A.
    Fung, Ho Yee Joyce
    Ranganathan, Parvathi
    Mitchell, Shaneice
    El-Gamal, Dalia
    Woyach, Jennifer A.
    Williams, Katie
    Goettl, Virginia M.
    Smith, Jordan L.
    Yu, Xueyan
    Meng, Xiaomei
    Sun, Qingxiang
    Cagatay, Tolga
    MacMillan, John B.
    Lehman, Amy M.
    Lucas, David M.
    Baloglu, Erkan
    Shacham, Sharon
    Kauffman, Michael
    Byrd, John C.
    Chook, Yuh Min
    Garzon, Ramiro
    Lapalombella, Rosa
    BLOOD, 2015, 126 (23)
  • [10] Nuclear Exporter Protein CRM1/XPO1 a Novel Prognostic and Therapeutic Target in Gastric Cancer
    Mahdi, Zaid
    Chaudhary, Rahman
    Muqbil, Irfana
    Aboukameel, Amro
    Mohammad, Ramzi
    Philip, Philip
    Senapedis, William
    Beydoun, Rafic
    Azmi, Asfar
    MODERN PATHOLOGY, 2017, 30 : 185A - 185A
12345